Epoetin Alfa Biosimilar Treatment for Chemotherapy-Induced Anemia in Current Oncology and Hematology Practice: An Iron Supplementation Subanalysis of the Synergy Study

Autor: Scotté, Florian, Laribi, Kamel, Gisselbrecht, Christian, Spaeth, Dominique, Kasdaghli, Emna, Albrand, Hélène, Leutenegger, Eric, Ray-Coquard, Isabelle
Zdroj: Blood; December 2015, Vol. 126 Issue: 23 p3363-3363, 1p
Abstrakt: Scotté: Hospira SAS: Research Funding. Laribi:Hospira SAS: Research Funding. Gisselbrecht:Bertram Glass: Research Funding; Chugai Pharmaceutical: Research Funding; Baxter: Research Funding; Roche: Consultancy, Research Funding; Hospira SAS: Research Funding. Spaeth:Hospira SAS: Research Funding. Kasdaghli:Hospira: Employment. Albrand:Hospira: Employment. Leutenegger:GECEM: Employment; Hospira SAS: Research Funding. Ray-Coquard:PharmaMar: Consultancy, Other: Paid instructor; Roche: Consultancy, Other: Paid instructor; Amgen: Consultancy, Other: Paid instructor; Hospira SAS: Research Funding.
Databáze: Supplemental Index